We use cookies to make your experience better. To comply with the new e-Privacy directive, we need to ask for your consent to set the cookies. Learn more.
anti-Dengue Envelope Antibody (Mouse - Clone #D1-11) - Monoclonal
| Antibody Type | Primary Antibody |
|---|---|
| Host | Mouse |
| Target Species | Infectious Disease |
| Specificity/Target | Dengue Envelope |
| Size | 1.0 |
| Clonality | Monoclonal |
| Type | Unconjugated |
| Isotype | IgG2a |
| Clone | D1-11 |
| Origin | USA |
| Shelf Life | 1 year |
| Format | Liquid |
| Buffer | Phosphate buffered saline (PBS), pH 7.2 |
| Preservative | 0.09% sodium azide |
| Storage | 2-8C |
| Application | ELISA |
| Purity | Antigen Affinity Purified |
Mouse anti-Dengue Envelope Protein Antibody
Crill WD, Hughes HR, Trainor NB, Davis BS, Whitney MT, Chang GJ. Sculpting humoral immunity through dengue vaccination to enhance protective immunity. Front Immunol. 2012;3:334. Published 2012 Nov 8. doi:10.3389/fimmu.2012.00334
Tan YY, Sekaran SD, Wang SM, Ahmed F, Hossain A, Sil BK. Development of ASSUREĀ® dengue IgA rapid test for the detection of anti-dengue IgA from dengue infected patients. J Global Infect Dis 2011;3:233-40
Grace Yap ,Bijon Kumar Sil , Lee-Ching Ng Use of Saliva for Early Dengue Diagnosis PLOS Published: May 10, 2011 DOI: 10.1371/journal.pntd.0001046
Matsui K, Gromowski GD, Li L, Barrett AD. Characterization of a dengue type-specific epitope on dengue 3 virus envelope protein domain III. J Gen Virol. 2010;91(Pt 9):2249-2253. doi:10.1099/vir.0.021220-0
Gromowski GD, Barrett ND, Barrett AD. Characterization of dengue virus complex-specific neutralizing epitopes on envelope protein domain III of dengue 2 virus. J Virol. 2008;82(17):8828-8837. doi:10.1128/JVI.00606-08
Volk DE, Lee YC, Li X, et al. Solution structure of the envelope protein domain III of dengue-4 virus. Virology. 2007;364(1):147-154. doi:10.1016/j.virol.2007.02.023

